TWD 361.5
(-0.14%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 583.47 Million TWD | 2.61% |
2022 | 568.62 Million TWD | -0.9% |
2021 | 573.77 Million TWD | 47.35% |
2020 | 389.4 Million TWD | -29.2% |
2019 | 549.99 Million TWD | -30.98% |
2018 | 796.9 Million TWD | 141.21% |
2017 | 330.37 Million TWD | 10.75% |
2016 | 298.29 Million TWD | -7.38% |
2015 | 322.05 Million TWD | 53.78% |
2014 | 209.42 Million TWD | 16.42% |
2013 | 179.89 Million TWD | -14.1% |
2012 | 209.42 Million TWD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 637.11 Million TWD | 9.19% |
2024 Q3 | 781.18 Million TWD | -0.24% |
2024 Q2 | 783.07 Million TWD | 22.91% |
2023 Q3 | 611.78 Million TWD | 11.81% |
2023 Q4 | 583.47 Million TWD | -4.63% |
2023 Q1 | 589.41 Million TWD | 3.66% |
2023 FY | 583.47 Million TWD | 2.61% |
2023 Q2 | 547.16 Million TWD | -7.17% |
2022 Q4 | 568.62 Million TWD | -13.54% |
2022 Q1 | 631.91 Million TWD | 10.13% |
2022 Q2 | 678.32 Million TWD | 7.34% |
2022 FY | 568.62 Million TWD | -0.9% |
2022 Q3 | 657.71 Million TWD | -3.04% |
2021 Q2 | 414.69 Million TWD | 5.75% |
2021 Q1 | 392.14 Million TWD | 0.7% |
2021 Q3 | 505.15 Million TWD | 21.82% |
2021 Q4 | 573.77 Million TWD | 13.58% |
2021 FY | 573.77 Million TWD | 47.35% |
2020 FY | 389.4 Million TWD | -29.2% |
2020 Q4 | 389.4 Million TWD | -26.7% |
2020 Q1 | 544.04 Million TWD | -1.08% |
2020 Q2 | 521.16 Million TWD | -4.2% |
2020 Q3 | 531.27 Million TWD | 1.94% |
2019 Q1 | - TWD | -100.0% |
2019 FY | 549.99 Million TWD | -30.98% |
2019 Q4 | 549.99 Million TWD | -19.31% |
2019 Q3 | 681.63 Million TWD | -7.97% |
2019 Q2 | 740.62 Million TWD | 0.0% |
2018 Q2 | 546.2 Million TWD | 0.0% |
2018 Q1 | - TWD | -100.0% |
2018 FY | 796.9 Million TWD | 141.21% |
2018 Q4 | 796.9 Million TWD | 0.0% |
2017 Q1 | 314.22 Million TWD | 5.34% |
2017 FY | 330.37 Million TWD | 10.75% |
2017 Q3 | 330.37 Million TWD | 5.14% |
2017 Q2 | 314.22 Million TWD | 0.0% |
2017 Q4 | 330.37 Million TWD | 0.0% |
2016 FY | 298.29 Million TWD | -7.38% |
2016 Q4 | 298.29 Million TWD | 0.0% |
2016 Q3 | 298.29 Million TWD | -3.64% |
2016 Q1 | 309.55 Million TWD | -3.88% |
2016 Q2 | 309.55 Million TWD | 0.0% |
2015 Q4 | 322.05 Million TWD | 0.0% |
2015 Q2 | 293.6 Million TWD | 0.0% |
2015 FY | 322.05 Million TWD | 53.78% |
2015 Q3 | 322.05 Million TWD | 9.69% |
2015 Q1 | 293.6 Million TWD | 40.2% |
2014 Q1 | 192.89 Million TWD | 7.23% |
2014 Q2 | 192.89 Million TWD | 0.0% |
2014 Q3 | 209.42 Million TWD | 8.57% |
2014 Q4 | 209.42 Million TWD | 0.0% |
2014 FY | 209.42 Million TWD | 16.42% |
2013 Q4 | 179.89 Million TWD | 0.0% |
2013 Q1 | - TWD | 0.0% |
2013 FY | 179.89 Million TWD | -14.1% |
2013 Q3 | 179.89 Million TWD | 0.0% |
2012 FY | 209.42 Million TWD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Nang Kuang Pharmaceutical Co., Ltd. | 705.32 Million TWD | 17.275% |
Maxigen Biotech Inc. | 85.18 Million TWD | -584.955% |
SciVision Biotech Inc. | 87.25 Million TWD | -568.729% |
Bionime Corporation | 491.25 Million TWD | -18.772% |
Visco Vision Inc. | 606.06 Million TWD | 3.727% |